Table 2.

Demographic, clinical characteristics, and cognitive assessment data

Items	Group A(n = 64)	Group B(n = 46)	t-value	p-value
Age	65(7)	69(13)	3.769	0.001**
Female, n(%)	44(68.7)	33(71.1)	1.264	0.736
Hypertension, n (%)	24(37.5)	13(31.7)	1.005	0.264
Hyperlipemia, n(%)	31(56.4)	20(57.1)	1.234	0.752
TC	4.52(1.08)	4.38 ± 0.16	0.883	0.586
TG	1.21(0.64)	1.50(0.98)	1.075	0.199
HDL	1.37 ± 0.56	1.27 ± 0.69	1.093	0.140
LDL	2.85 ± 0.10	2.61(1.42)	1.064	0.276
MMSE	29.00(1.00)	29.00(2.00)	1.089	0.091
MOCA	24.00(5.00)	24.00(5.00)	1.080	0.095

Values with normal distribution are presented as the mean ± stand deviation (SD); Values with non-normal distribution are presented as median (interquartile range)

TC: total cholesterol; TG: triglyceride; HDL: high density lipoprotein; LDL: low density lipoprotein; MMSE: mini-mental state examination; MoCA: montreal cognitive assessment; The Group A = WMH low rating group. The Group B = WMH high rating group

*: The difference between groups was statistically significant(p < 0.05)

Wang Y, Liu X, Hu Y, Yu Z, Wu T, Wang J, Liu J, Liu J. Impaired functional network properties contribute to white matter hyperintensity related cognitive decline in patients with cerebral small vessel disease. BMC MED IMAGING 2022;22:40. The current article included the same subjects and grouping criteria as previously published article. According to the regulations of BMC Medical Imaging, as an author of an article published in BMC Medical Imaging, we retain the copyright of our article and we are free to reproduce and disseminate our work